We are live on ! Find out more
GSK icon

GSK
GSK

895 hedge funds and large institutions have $11.1B invested in GSK in 2023 Q4 according to their latest regulatory filings, with 127 funds opening new positions, 270 increasing their positions, 345 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

118% more call options, than puts

Call options by funds: $227M | Put options by funds: $104M

102% more first-time investments, than exits

New positions opened: 127 | Existing positions closed: 63

8% more funds holding in top 10

Funds holding in top 10: 12 → 13 (+1)

7% more capital invested

Capital invested by funds: $10.4B → $11.1B (+$753M)

6% more funds holding

Funds holding: 846 → 895 (+49)

0.3% more ownership

Funds ownership: 6.98% → 7.28% (+0.3%)

22% less repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 345

Holders
895
Holders Change
+49
Holders Change %
+5.79%
% of All Funds
13.05%
Holding in Top 10
13
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+8.33%
% of All Funds
0.19%
New
127
Increased
270
Reduced
345
Closed
63
Calls
$227M
Puts
$104M
Net Calls
+$123M
Net Calls Change
-$164M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$343M
2
Holocene Advisors
Holocene Advisors
New York
+$115M
3
HSBC Holdings
HSBC Holdings
United Kingdom
+$89.6M
4
MIP
Mondrian Investment Partners
United Kingdom
+$77.3M
5
AC
Armistice Capital
New York
+$68.6M

Top Sellers

1
Deutsche Bank
Deutsche Bank
Germany
-$159M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$107M
3
Goldman Sachs
Goldman Sachs
New York
-$43.6M
4
Millennium Management
Millennium Management
New York
-$42.4M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$38.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
MFA
851
McClarren Financial Advisors
Pennsylvania
$4K +$3.63K +101 New
NC
852
NewSquare Capital
Pennsylvania
$3.96K – – –
HIA
853
Harbor Investment Advisory
Maryland
$3.85K – – –
FG
854
Fairman Group
Pennsylvania
$3.74K +$3.59K +100 New
SIC
855
SJS Investment Consulting
Ohio
$3.71K +$3.59K +100 New
CAM
856
Creekmur Asset Management
Illinois
$3.63K +$3.52K +98 New
TCM
857
Tradewinds Capital Management
Washington
$3.6K – – –
BIA
858
Bell Investment Advisors
California
$3.52K -$538 -15 -14%
AWM
859
Able Wealth Management
New Jersey
$3.48K +$3.38K +94 New
LOIP
860
Live Oak Investment Partners
Texas
$3.19K – – –
OC
861
Oakworth Capital
Alabama
$2.96K – – –
TCM
862
TD Capital Management
Tennessee
$2.96K – – –
AP
863
Aspect Partners
Virginia
$2.96K +$2.87K +80 New
CPA
864
Clear Point Advisors
New York
$2.96K +$2.87K +80 New
PCWA
865
Pacific Capital Wealth Advisors
California
$2.96K +$2.87K +80 New
WPWM
866
Western Pacific Wealth Management
Illinois
$2.84K +$36 +1 +1%
KFS
867
Kelly Financial Services
Massachusetts
$2.38K +$36 +1 +2%
RCM
868
Raleigh Capital Management
North Carolina
$2.35K – – –
BCM
869
Bourgeon Capital Management
Connecticut
$2.33K +$1.15K +32 +103%
TVAMP
870
Tennessee Valley Asset Management Partners
Tennessee
$2.26K +$2.19K +61 New
FFA
871
Frazier Financial Advisors
Ohio
$2.15K +$2.08K +58 New
BAM
872
Byrne Asset Management
New Jersey
$2.08K – – –
KFP
873
Keener Financial Planning
Texas
$2K +$1.65K +46 New
BONH
874
Bank of New Hampshire
New Hampshire
$1.71K -$2.08K -58 -56%
RG
875
Retirement Group
California
$1.48K – – –
33 34
35
36 37

GSK Hedge Fund Activity: Q4 2023 in Review

895 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q4 2023, worth a combined $11.1B — up 7.3% from $10.4B a quarter earlier.

Buyers outnumbered sellers: 127 funds opened new GSK positions and 63 closed out — a net gain of 64 holders — while 270 added to existing stakes and 345 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $343M. The largest seller was Deutsche Bank, cutting an estimated $159M.

  • 895 institutional investors held GSK (GSK) as of Q4 2023, up from 846 in Q3 2023.
  • Funds reported $11.1B of GSK stock for Q4 2023, up 7.3% quarter-over-quarter.
  • 127 funds opened new GSK positions in Q4 2023 and 63 closed out, a net change of +64 holders.
  • The largest GSK buyer in Q4 2023 was Morgan Stanley, an estimated $343M added.
  • The largest GSK seller in Q4 2023 was Deutsche Bank, an estimated $159M sold.

Based on aggregated 13F filings for Q4 2023.